Autonomix Medical Valuation
| AMIX Stock | 0.40 0.02 4.76% |
Autonomix Medical is overvalued. Autonomix Medical Common shows a prevailing Real Value of USD0.38 per share. The current price of the firm is USD0.4. Our model approximates the value of Autonomix Medical Common from analyzing the firm fundamentals such as Shares Owned By Insiders of 6.71 %, return on equity of -3.52, and Current Valuation of (7.93 M) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Autonomix Medical's price fluctuation is out of control at this time. Calculation of the real value of Autonomix Medical Common is based on 3 months time horizon. Increasing Autonomix Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Autonomix Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Autonomix Stock. However, Autonomix Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.4 | Real 0.38 | Target 6.6 | Hype 0.4 | Naive 0.28 |
The intrinsic value of Autonomix Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Autonomix Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Autonomix Medical Common helps investors to forecast how Autonomix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Autonomix Medical more accurately as focusing exclusively on Autonomix Medical's fundamentals will not take into account other important factors: Autonomix Medical Cash |
|
Autonomix Medical Total Value Analysis
Autonomix Medical Common is presently forecasted to have valuation of (7.93 M) with market capitalization of 2.75 M, debt of 1.71 M, and cash on hands of . The negative valuation of Autonomix Medical may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Autonomix Medical fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(7.93 M) | 2.75 M | 1.71 M |
Autonomix Medical Asset Utilization
One of the ways to look at asset utilization of Autonomix is to check how much profit was generated for every dollar of assets it reports. Autonomix Medical Common shows a negative utilization of assets of -1.59 percent, losing USD0.0159 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Autonomix Medical Common shows how discouraging it operates for each dollar spent on its assets.Autonomix Medical Profitability Analysis
Taking into consideration Autonomix Medical's profitability measurements, Autonomix Medical Common may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Autonomix Medical's ability to earn profits and add value for shareholders.Net Loss | First Reported 2010-12-31 | Previous Quarter -10.3 M | Current Value -10.8 M | Quarterly Volatility 2.9 M |
For Autonomix Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Autonomix Medical Common to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Autonomix Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Autonomix Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Autonomix Medical over time as well as its relative position and ranking within its peers.
Autonomix Medical Earnings per Share Projection vs Actual
By analyzing Autonomix Medical's earnings estimates, investors can diagnose different trends across Autonomix Medical's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Autonomix Medical Common is based on EPS before non-recurring items and includes expenses related to employee stock options.Autonomix Medical Ownership Allocation
Autonomix Medical Common shows 6.71 percent of its outstanding shares held by insiders and 4.77 percent owned by other corporate entities.Autonomix Medical Profitability Analysis
Net Loss for the year was (11.41 M) with profit before overhead, payroll, taxes, and interest of 0.About Autonomix Medical Valuation
Our relative valuation model uses a comparative analysis of Autonomix Medical. We calculate exposure to Autonomix Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Autonomix Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -164.7 K | -172.9 K |
Autonomix Medical Current Valuation Indicators
Valuation refers to the process of determining the present value of Autonomix Medical Common and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Autonomix we look at many different elements of the entity such as Autonomix's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Autonomix Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Autonomix Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Autonomix Medical's worth.Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.